Keyphrases
Acetamide
20%
Acute Kidney Injury
40%
Acute Kidney Injury Treatment
20%
Aminomethyl
20%
Arginase-1 (Arg-1)
20%
Benzyl
20%
Bilateral Renal Ischemia
20%
C-Myc
20%
CD38
20%
Clusterin
20%
Fibroblast Growth factor-2 (FGF-2)
20%
FPR2
20%
High Morbidity
20%
High Mortality
20%
Inducible Nitric Oxide Synthase
60%
Inducible Nitric Oxide Synthase Inhibitors
20%
Inflammation
20%
Interleukin-6
20%
Ischemia Injury
100%
Ischemia-reperfusion Injury
100%
Kidney Cortex
20%
Kidney Disease
20%
Kidney Injury
20%
Kidney Medulla
20%
Kidney Morphology
20%
Macrophage Polarization
40%
Medulla
100%
Mesenchymal Transition
20%
Molecular Targets
20%
Morphological Defects
20%
Murine Model
100%
Nephrogenetics
20%
Nitric Oxide Synthase Inhibition
20%
Opportunity to Use
20%
Periodic acid-Schiff
20%
Pharmacological Inhibitors
20%
Quantitative PCR
20%
Renal Cortex
100%
Renal Injury
100%
Renal Medulla
60%
Reperfusion
20%
Therapeutic Approaches
20%
Vimentin
20%
Pharmacology, Toxicology and Pharmaceutical Science
Acetamide
14%
Acute Kidney Failure
42%
Clusterin
14%
Fibroblast Growth Factor 2
14%
Inducible Nitric Oxide Synthase
57%
Inflammation
14%
Interleukin 6
14%
Ischemia
100%
Kidney Dysfunction
14%
Kidney Injury
100%
Kidney Ischemia
14%
Molecular Target
14%
N [3 (Aminomethyl)benzyl]acetamidine
100%
Neutrophil Gelatinase Associated Lipocalin
14%
Nitric Oxide Synthase Inhibitor
14%
Periodic Acid
14%
Reperfusion Injury
100%
Tumor Necrosis Factor
14%
Vimentin
14%